www.fdanews.com/articles/113711-elan-clarifies-reported-news-on-bapineuzumab-phase-3-trials-duration

Elan Clarifies Reported News on Bapineuzumab Phase 3 Trials Duration

January 13, 2009

Elan Corp. clarified the recent reports that stated that the duration of the bapineuzumab Phase 3 clinical trials may be extended.
RTTNews